IDEXX launches point-of-care cardiac test for cats and dogs

Go back to IDEXX launches point-of-care cardiac test for cats and dogs

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test

August 11, 2026 7:00 AM EDT

New test brings quantitative cardiac assessment for cats and dogs into everyday workflows

WESTBROOK, Maine--(BUSINESS WIRE)-- IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst proBNP Test, the first and only dual-species, in-clinic test for NT-proBNP, expanding cardiac capabilities across... More